DEVELOPMENT OF CYTOKINE ADSORPTION COLUMN AND THE TREATMENT OF MULTIPLE ORGAN FAILURE BY CYTOKINE ADSORPTION COLUMN
DEVELOPMENT OF CYTOKINE ADSORPTION COLUMN AND THE TREATMENT OF MULTIPLE ORGAN FAILURE BY CYTOKINE ADSORPTION COLUMN
批准号:
13671216
负责人:
ODA Shigeto
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cytokines plays an important role in the pathophysiology of multiple organ failure (MOF). This study was undertaken to develop a cytokine adsorption column, which selectively removes cytokines from blood stream, and to establish a new therapeutic modality for the treatment of MOF. Various adsorbents, which are already clinically applied as immunoadsorption columns for the treatment of various diseases or under development were investigated on their cytokine adsorptive property for development of a new cytokine adsorption column. Among tested adsorbents, Lixelle β2-adsorbing column for dialysis related amyloidosis) and CF-X (developing as an immunoadsorption column for autoimmune diseases) have been. revealed to have high affinity to various cytokines and these adsorbents were selected for the development of a cytokine adsorption column. Although CF-X had the highest affinity to TNF-α, it also adsorbed normal γ-globulin. Therefore, a new MPC coated adsorbent (MPC-FX) was developed. MPC-FX could effectively adsorb various cytokines without adsorbing normal Ig G. However, the development of MPC-FX column abandoned because of circumstances of company. A new adsorbent T-SAAF, which was developed to adsorb super antigen of gram positive bacteria, was tested. T-SAAF has been revealed to adsorb various cytokines in vitro study. T-SAAF has been evaluated its safety and efficacy in animal models. Clinical trials would be started near future. In a clinical study, indication of cytokine adsorption columns was studied with rapid measurement system of blood IL-6. Patients with IL-6 blood levels >10,000pg/mL were difficult to control hypercytokinemia even with PMMA-CHDF and had poor prognosis. It was confirmed that genetic polymorphisms in cytokine related genes were related to hypercytokinemia among these patients. These patients. would be good candidates for the application of a cytokine adsorption column.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
織田成人 他: "腹部救急疾患に合併した敗血症性ショックに対する治療戦略"日本腹部救急医学会雑誌. 22・5. 791-799 (2002)
Shigeto Oda 等:“感染性休克并发腹部急症的治疗策略”日本腹部急症医学会杂志 22・5(2002 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
織田成人, 平澤博之, 志賀英敏, 松田兼一, 上野博一, 仲村将高, 渡遅栄三: "重症感染症の病態とメディエーター"日本外科学会雑誌. 104. 511-517 (2003)
Shigeto Oda、Hiroyuki Hirasawa、Hidetoshi Shiga、Kenichi Matsuda、Hirokazu Ueno、Masataka Nakamura、Eizo Watanabe:“严重感染性疾病的病理学和介质”日本外科学会杂志 104. 511-517 (2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamura M: "Therapeutic strategy for patients with septic shock complicated abdominal emergency"Journal of Abdominal Emergency Medicine. 22. 791-799 (2002)
Oda S、Hirasawa H、Shiga H、Nakanishi K、Matsuda K、Nakamura M:“脓毒性休克并发腹部急症患者的治疗策略”腹部急诊医学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kenichi Matsuda, et al.: "Current topics in cytokine removal technologies"Therapeutic Apheresis. 5・4. 306-314 (2001)
Kenichi Matsuda 等人:“细胞因子去除技术的当前主题”治疗性血浆分离术 5・4(2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamura M: "Continuous hemofilitration/hemodiafiltration in critical care"Therapeutic Apheresis. 6. 193-198 (2002)
Oda S、Hirasawa H、Shiga H、Nakanishi K、Matsuda K、Nakamura M:“重症监护中的连续血液滤过/血液透析滤过”治疗性血浆分离术。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 20 条
Possibility of treatment with erythropoietin for anemia in critically ill patients
-
批准号:15K15660
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2015
-
负责人:ODA Shigeto
-
依托单位:
Tailor-made medicine based on genetic polymorphism analyses in relation to biological and immunological responses
-
批准号:22390335
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.23万
-
财政年份:2010
-
负责人:ODA Shigeto
-
依托单位:
Order-made therapy based on analysis of genetic polymorphism related to cytokine production
-
批准号:19390457
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.48万
-
财政年份:2007
-
负责人:ODA Shigeto
-
依托单位:
Tailor-made therapy for patients with septic multiple organ failure using a cytokine adsorbing column based on genetic analysis of cytokine related gene polymorphisms
-
批准号:16390514
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.36万
-
财政年份:2004
-
负责人:ODA Shigeto
-
依托单位:
Establishment of a new Severity Scoring System for the Patients with Multiple Organ Failure from the Aspect of Cellular Injury - Anoxic Necrosis and Apoptosis
-
批准号:10671098
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:1998
-
负责人:ODA Shigeto
-
依托单位:
A STUDY ON THE TREATMENT FOR SEPTIC MULTIPLE ORGAN FAILURE THROUGH IMPROVEMENT OF TISSUE OXYGEN METABOLISM
-
批准号:06671506
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.28万
-
财政年份:1994
-
负责人:ODA Shigeto
-
依托单位:
海外基金